Does Immunotherapy Before Breast Cancer Surgery Offer Benefits? – Heard in the Halls: Voices From the 2019 SABCS

episode

Breastcancer.org Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-24-2026 5AM EDT 5 min · 24 Sep 2026 · NPR News Now

Busting Brain Myths: TikTok's Viral Neuroscientist 11 min · 24 Sep 2026 · Today with David McCullagh

Classic Suze School: The Keys to a Successful Relationship 20 min · 24 Sep 2026 · Suze Orman's Women & Money (And Everyone Smart Enough To Listen)

Give Yourself a Year to Try 12 New Things and Embrace Change 39 min · 24 Sep 2026 · The Oprah Podcast

We Investigated the Christian "Scam" Fronted by Tim Tebow 1h 17m · 24 Sep 2026 · Pablo Torre Finds Out

Trump threatens Iran in fiery UN speech. What's next? 14 min · 24 Sep 2026 · The Excerpt

Report any issue

Source

Recorded07 Jan 2020

Publisherfeeds.megaphone.fm ↗

Handlerec:11088249

Show notes

Dr. Luca Gianni, president of the Fondazione Michelangelo in Milan, discusses the results of the NeoTRIP trial, which looked to see if adding the immunotherapy medicine Tecentriq (chemical name: atezolizumab) to chemotherapy before surgery for triple-negative breast cancer with a high risk of recurrence could improve the time women lived without the cancer coming back.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in